ArticleCureus2025
Delayed Diagnosis Salicylate Toxicity With Confirmed Cerebrospinal Fluid Salicylate Concentration: A Case Report of Altered Mental Status Without Neuroglycopenia and With Coagulopathy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salicylate toxicity usually occurs as a result of elevated serum salicylate concentrations. Salicylate concentrations can be measured in cerebrospinal fluid (CSF), but the interpretation of these values is less well understood. Two phenomena believed to be associated with salicylate toxicity are neuroglycopenia and salicylate-induced coagulopathy, but these cases are typically not well-characterized. We report a case of delayed diagnosis of salicylate toxicity that was complicated by coagulopathy and had a quantifiable CSF salicylate concentration. An 18-year-old female patient presented with abdominal pain and an altered mental state; she had previously presented at another hospital one day prior. She did not initially report salicylate overdose. A lumbar puncture was performed 4.5 hours after emergency department (ED) presentation to rule out meningitis. Due to additional history, a serum salicylate concentration obtained at 25 hours led to a result of 48.8 mg/dL (therapeutic range: 15-30 mg/dL). Hemodialysis (HD) was performed 37 hours after ED presentation due to the altered mental state. Prior to HD, the patient had a prothrombin time of 63 seconds (reference range: 11-13 seconds), international normalized ratio of 5.52 (reference range: 0.8-1.1), and activated partial thromboplastin time of 40.2 seconds (reference range: 25-35 seconds). After the case conclusion, waste CSF was tested and the CSF salicylate concentration was 23 mg/dL; the corresponding CSF and serum glucose concentrations were 60 mg/dL (reference range: 50-75 mg/dL) and 87 mg/dL (reference range: 70-99 mg/dL), respectively. This is a case of delayed diagnosis salicylate poisoning complicated by coagulopathy, without neuroglycopenia. Although we do not recommend routine CSF testing in salicylate toxicity cases, analysis of CSF could shed insight into salicylate-induced encephalopathy. This case illustrates that prompt recognition and treatment of toxicity is key, as delayed diagnosis can increase morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.